3M in Talks to License Drug Delivery Technologies

U.S.-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to license drug delivery technologies. As a leading provider of asthma inhaler solutions to Indian companies, 3M plans to partner these firms in developing medicines which can be delivered through the skin (transdermal drug delivery).
The Economic Times